| [1] |
CORREA-DE-ARAUJO R, ADDISON O, MILJKOVIC I, et al. Myosteatosis in the context of skeletal muscle function deficit: An interdisciplinary workshop at the national institute on aging[J]. Front Physiol, 2020, 11: 963. DOI: 10.3389/fphys.2020.00963.
|
| [2] |
KOTEISH A, DIEHL AM. Animal models of steatosis[J]. Semin Liver Dis, 2001, 21( 1): 89- 104. DOI: 10.1055/s-2001-12932.
|
| [3] |
KIRKLAND JL, TCHKONIA T, PIRTSKHALAVA T, et al. Adipogenesis and aging: Does aging make fat go MAD?[J]. Exp Gerontol, 2002, 37( 6): 757- 767. DOI: 10.1016/s0531-5565(02)00014-1.
|
| [4] |
FARUP J, MADARO L, PURI PL, et al. Interactions between muscle stem cells, mesenchymal-derived cells and immune cells in muscle homeostasis, regeneration and disease[J]. Cell Death Dis, 2015, 6( 7): e1830. DOI: 10.1038/cddis.2015.198.
|
| [5] |
SCHRAUWEN-HINDERLING VB, KOOI ME, HESSELINK MC, et al. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects[J]. Diabetologia, 2007, 50( 1): 113- 120. DOI: 10.1007/s00125-006-0475-1.
|
| [6] |
HIBI T, WEI CHIEH AK, CHAN AC, et al. Current status of liver transplantation in Asia[J]. Int J Surg, 2020, 82S: 4- 8. DOI: 10.1016/j.ijsu.2020.05.071.
|
| [7] |
KAIDO T. Recent evolution of living donor liver transplantation at Kyoto University: How to achieve a one-year overall survival rate of 99%?[J]. Hepatobiliary Pancreat Dis Int, 2020, 19( 4): 328- 333. DOI: 10.1016/j.hbpd.2020.06.006.
|
| [8] |
DUTKOWSKI P, OBERKOFLER CE, SLANKAMENAC K, et al. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era[J]. Ann Surg, 2011, 254( 5): 745-753; discussion753. DOI: 10.1097/SLA.0b013e3182365081.
|
| [9] |
BRAAT AE, BLOK JJ, PUTTER H, et al. The Eurotransplant donor risk index in liver transplantation: ET-DRI[J]. Am J Transplant, 2012, 12( 10): 2789- 2796. DOI: 10.1111/j.1600-6143.2012.04195.x.
|
| [10] |
RANA A, JIE T, PORUBSKY M, et al. The survival outcomes following liver transplantation(SOFT) score: Validation with contemporaneous data and stratification of high-risk cohorts[J]. Clin Transplant, 2013, 27( 4): 627- 632. DOI: 10.1111/ctr.12181.
|
| [11] |
POMMERGAARD HC, DAUGAARD TR, ROSTVED AA, et al. Model for end-stage liver disease score predicts complications after liver transplantation[J]. Langenbecks Arch Surg, 2021, 406( 1): 55- 65. DOI: 10.1007/s00423-020-02018-3.
|
| [12] |
SCHLEGEL A, LINECKER M, KRON P, et al. Risk assessment in high- and low-MELD liver transplantation[J]. Am J Transplant, 2017, 17( 4): 1050- 1063. DOI: 10.1111/ajt.14065.
|
| [13] |
CZIGANY Z, KRAMP W, BEDNARSCH J, et al. Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation[J]. Am J Transplant, 2020, 20( 2): 493- 503. DOI: 10.1111/ajt.15577.
|
| [14] |
CZIGANY Z, KRAMP W, LURJE I, et al. The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation[J]. J Cachexia Sarcopenia Muscle, 2021, 12( 2): 358- 367. DOI: 10.1002/jcsm.12669.
|
| [15] |
MEISTER FA, BEDNARSCH J, AMYGDALOS I, et al. Various myosteatosis selection criteria and their value in the assessment of short- and long-term outcomes following liver transplantation[J]. Sci Rep, 2021, 11( 1): 13368. DOI: 10.1038/s41598-021-92798-5.
|
| [16] |
SHENVI SD, TABER DJ, HARDIE AD, et al. Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients[J]. HPB(Oxford), 2020, 22( 1): 102- 108. DOI: 10.1016/j.hpb.2019.06.006.
|
| [17] |
AHN H, KIM DW, KO Y, et al. Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: A new paradigm beyond sarcopenia[J]. Ageing Res Rev, 2021, 70: 101398. DOI: 10.1016/j.arr.2021.101398.
|
| [18] |
FARON A, SPRINKART AM, KUETTING DLR, et al. Body composition analysis using CT and MRI: Intra-individual intermodal comparison of muscle mass and myosteatosis[J]. Sci Rep, 2020, 10( 1): 11765. DOI: 10.1038/s41598-020-68797-3.
|
| [19] |
DINDO D, DEMARTINES N, CLAVIEN PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6 336 patients and results of a survey[J]. Ann Surg, 2004, 240( 2): 205- 213. DOI: 10.1097/01.sla.0000133083.54934.ae.
|
| [20] |
XU X, YANG JY, ZHONG L, et al. The clinical value of“Hangzhou Criteria” in the selection of patients with hepatocellular carcinoma for liver transplantation: A report of 1 163 cases on a multi-center basis[J]. Chin J Organ Transplant, 2013, 34( 9): 524- 527. DOI: 10.3760/cma.j.issn.0254-1785.2013.09.004.
徐骁, 杨家印, 钟林, 等. 肝癌肝移植“杭州标准”的多中心应用研究: 1 163例报道[J]. 中华器官移植杂志, 2013, 34( 9): 524- 527. DOI: 10.3760/cma.j.issn.0254-1785.2013.09.004.
|
| [21] |
MARTIN L, BIRDSELL L, MACDONALD N, et al. Cancer Cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index[J]. J Clin Oncol, 2013, 31( 12): 1539- 1547. DOI: 10.1200/JCO.2012.45.2722.
|
| [22] |
LI MY, LI XY, GUO Y, et al. Development and assessment of an individualized nomogram to predict colorectal cancer liver metastases[J]. Quant Imaging Med Surg, 2020, 10( 2): 397- 414. DOI: 10.21037/qims.2019.12.16.
|
| [23] |
van GRIETHUYSEN JJM, FEDOROV A, PARMAR C, et al. Computational radiomics system to decode the radiographic phenotype[J]. Cancer Res, 2017, 77( 21): e104- e107. DOI: 10.1158/0008-5472.CAN-17-0339.
|
| [24] |
HAMAGUCHI Y, KAIDO T, OKUMURA S, et al. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation[J]. Liver Transpl, 2014, 20( 11): 1413- 1419. DOI: 10.1002/lt.23970.
|
| [25] |
HAMAGUCHI Y, KAIDO T, OKUMURA S, et al. Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation[J]. J Cachexia Sarcopenia Muscle, 2018, 9( 2): 246- 254. DOI: 10.1002/jcsm.12276.
|
| [26] |
ZHUANG CL, SHEN X, HUANG YY, et al. Myosteatosis predicts prognosis after radical gastrectomy for gastric cancer: A propensity score-matched analysis from a large-scale cohort[J]. Surgery, 2019, 166( 3): 297- 304. DOI: 10.1016/j.surg.2019.03.020.
|
| [27] |
KIM DW, KIM KW, KO Y, et al. Assessment of myosteatosis on computed tomography by automatic generation of a muscle quality map using a web-based toolkit: Feasibility study[J]. JMIR Med Inform, 2020, 8( 10): e23049. DOI: 10.2196/23049.
|
| [28] |
SJØBLOM B, GRØNBERG BH, WENTZEL-LARSEN T, et al. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer[J]. Clin Nutr, 2016, 35( 6): 1386- 1393. DOI: 10.1016/j.clnu.2016.03.010.
|
| [29] |
BOWDEN JS, WILLIAMS LJ, SIMMS A, et al. Prediction of 90 day and overall survival after chemoradiotherapy for lung cancer: Role of performance status and body composition[J]. Clin Oncol(R Coll Radiol), 2017, 29( 9): 576- 584. DOI: 10.1016/j.clon.2017.06.005.
|
| [30] |
KUMAR A, MOYNAGH MR, MULTINU F, et al. Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer[J]. Gynecol Oncol, 2016, 142( 2): 311- 316. DOI: 10.1016/j.ygyno.2016.05.027.
|
| [31] |
AUST S, KNOGLER T, PILS D, et al. Skeletal muscle depletion and markers for cancer Cachexia are strong prognostic factors in epithelial ovarian cancer[J]. PLoS One, 2015, 10( 10): e0140403. DOI: 10.1371/journal.pone.0140403.
|
| [32] |
van RIJSSEN LB, van HUIJGEVOORT NM, COELEN RS, et al. Skeletal muscle quality is associated with worse survival after pancreatoduodenectomy for periampullary, nonpancreatic cancer[J]. Ann Surg Oncol, 2017, 24( 1): 272- 280. DOI: 10.1245/s10434-016-5495-6.
|
| [33] |
OKUMURA S, KAIDO T, HAMAGUCHI Y, et al. Visceral adiposity and sarcopenic visceral obesity are associated with poor prognosis after resection of pancreatic cancer[J]. Ann Surg Oncol, 2017, 24( 12): 3732- 3740. DOI: 10.1245/s10434-017-6077-y.
|
| [34] |
TAMANDL D, PAIREDER M, ASARI R, et al. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer[J]. Eur Radiol, 2016, 26( 5): 1359- 1367. DOI: 10.1007/s00330-015-3963-1.
|
| [35] |
CHU MP, LIEFFERS J, GHOSH S, et al. Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy[J]. J Cachexia Sarcopenia Muscle, 2017, 8( 2): 298- 304. DOI: 10.1002/jcsm.12161.
|
| [36] |
BOER BC, de GRAAFF F, BRUSSE-KEIZER M, et al. Skeletal muscle mass and quality as risk factors for postoperative outcome after open colon resection for cancer[J]. Int J Colorectal Dis, 2016, 31( 6): 1117- 1124. DOI: 10.1007/s00384-016-2538-1.
|
| [37] |
van DIJK DPJ, BAKENS MJAM, COOLSEN MME, et al. Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer[J]. J Cachexia Sarcopenia Muscle, 2017, 8( 2): 317- 326. DOI: 10.1002/jcsm.12155.
|
| [38] |
AKAHORI T, SHO M, KINOSHITA S, et al. Prognostic significance of muscle attenuation in pancreatic cancer patients treated with neoadjuvant chemoradiotherapy[J]. World J Surg, 2015, 39( 12): 2975- 2982. DOI: 10.1007/s00268-015-3205-3.
|